Close

Mallinckrodt (MNK), Lannett (LCI) Price Targets Lowered at Deutsche Bank After FDA Proposes to Withdraw ANDAs for Methylphenidate ER

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. JNJ
4. AMD
5. GS
6. BAC
7. MS
8. BK
9. UNH
10. SCHW


Go back to Mallinckrodt (MNK), Lannett (LCI) Price Targets Lowered at Deutsche Bank After FDA Proposes to Withdraw ANDAs for Methylphenidate ER

Mallinckrodt (MNK) Valuation Range, Estimates Cut at Wells Fargo on Methyphenidate ER Issue

October 18, 2016 7:59 AM EDT

Wells Fargo analyst David Maris lowered his valuation range on Mallinckrodt plc (NYSE: MNK) from $88-$89 to $83-$84 after the the FDA announced a proposal to withdraw approval of an ANDA for methylphenidate hydrochloride (HCl) extended-release (ER) tablets.

The firm lowered Q4 estimate by... More